Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
作者信息
Chiumente Marco, Messori Andrea
机构信息
Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italy.
Health Technology Assessment Unit, ESTAR Toscana, Regional Health Service, Via San Salvi 12, 50100 Florence, Italy.
出版信息
Ther Adv Musculoskelet Dis. 2017 Oct;9(10):271-273. doi: 10.1177/1759720X17721151. Epub 2017 Aug 23.
Abstract
摘要
相似文献
1
Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
Ther Adv Musculoskelet Dis. 2017 Oct;9(10):271-273. doi: 10.1177/1759720X17721151. Epub 2017 Aug 23.
2
Comparative efficacy and safety of biosimilar rituximab and originator rituximab in combination with methotrexate in patients with active rheumatoid arthritis: A Bayesian network meta-analysis
.
Int J Clin Pharmacol Ther. 2019 Apr;57(4):188-196. doi: 10.5414/CP203360.
3
Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis.
BioDrugs. 2019 Oct;33(5):469-483. doi: 10.1007/s40259-019-00376-z.
4
Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1118. Epub 2018 Mar 20.
5
"Total evidence" network meta-analysis as a tool for improving the assessment of biosimilars: application to etanercept in rheumatoid arthritis
.
Int J Clin Pharmacol Ther. 2017 Jun;55(6):517-520. doi: 10.5414/CP202877.
6
Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
Clin Rheumatol. 2018 May;37(5):1199-1205. doi: 10.1007/s10067-018-4002-9. Epub 2018 Feb 1.
7
Trastuzumab biosimilar in metastatic breast cancer: Evaluating equivalence with originator using network meta-analysis
.
Int J Clin Pharmacol Ther. 2019 Mar;57(3):160-162. doi: 10.5414/CP203351.
8
Comparative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta-analysis of randomized controlled trials.
Int J Rheum Dis. 2018 May;21(5):922-929. doi: 10.1111/1756-185X.13305. Epub 2018 Apr 19.
9
Biosimilars Have Arrived: Rituximab.
Arthritis. 2018 Mar 22;2018:3762864. doi: 10.1155/2018/3762864. eCollection 2018.
10
Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
Rheumatol Int. 2017 Jun;37(6):1007-1014. doi: 10.1007/s00296-017-3663-z. Epub 2017 Feb 18.
本文引用的文献
1
"Total evidence" network meta-analysis as a tool for improving the assessment of biosimilars: application to etanercept in rheumatoid arthritis
.
Int J Clin Pharmacol Ther. 2017 Jun;55(6):517-520. doi: 10.5414/CP202877.
2
Network meta-analysis as a tool for improving the effectiveness assessment of biosimilars based on both direct and indirect evidence: application to infliximab in rheumatoid arthritis.
Eur J Clin Pharmacol. 2017 Apr;73(4):513-514. doi: 10.1007/s00228-016-2177-z. Epub 2016 Dec 14.
3
Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.
BioDrugs. 2016 Dec;30(6):585-592. doi: 10.1007/s40259-016-0202-5.
4
A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis.
Ann Rheum Dis. 2017 Mar;76(3):566-570. doi: 10.1136/annrheumdis-2016-209540. Epub 2016 Sep 13.
5
6
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)).
Ann Rheum Dis. 2010 Sep;69(9):1629-35. doi: 10.1136/ard.2009.119933. Epub 2010 May 20.
7
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
Arthritis Rheum. 2006 May;54(5):1390-400. doi: 10.1002/art.21778.
8
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.
N Engl J Med. 2004 Jun 17;350(25):2572-81. doi: 10.1056/NEJMoa032534.
Zotero 插件